The Patent Finder

B. Twelve, Inc.

Also on record
Records under this name other than patents B. Twelve, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 5 of 5 · Back to B. Twelve, Inc.

PatentTitleStatus Expires Confidence
US 5,688,504Anti-receptor and growth blocking antibodies to the vitamin B.sub.12 /transcobalamin II receptor and binding sites
Term ended
Term ended no later than Nov 18, 2017 · Low confidence
Term endedTerm ended no later than Nov 18, 2017Low confidence
US 5,739,287Biotinylated cobalamins
Term ended
Term ended no later than Apr 14, 2018 · Low confidence
Term endedTerm ended no later than Apr 14, 2018Low confidence
US 5,840,712Water soluble vitamin B.sub.12 receptor modulating agents and methods related thereto
Term ended
Term ended no later than Nov 24, 2018 · Low confidence
Term endedTerm ended no later than Nov 24, 2018Low confidence
US 5,840,880Receptor modulating agents
Term ended
Term ended no later than Nov 24, 2018 · Low confidence
Term endedTerm ended no later than Nov 24, 2018Low confidence
US 5,869,465Methods of receptor modulation and uses therefor
Term ended
Term ended no later than Feb 9, 2019 · Low confidence
Term endedTerm ended no later than Feb 9, 2019Low confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited